Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Adenocarcinoma and CTLA4[original query] |
---|
High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Human immunology 2007 Aug 68 (8): 698-704. Cozar Jose M, Romero Jose M, Aptsiauri Natalia, Vazquez Fernando, Vilchez Jose R, Tallada Miguel, Garrido Federico, Ruiz-Cabello Francis |
Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma. Scandinavian journal of immunology 2015 Dec . Tang Weifeng, Wang Yafeng, Chen Shuchen, Lin Jihong, Chen Boyang, Yu Shaobin, Chen Yu, Gu Haiyong, Kang Mingqia |
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET. European review for medical and pharmacological sciences 2020 9 24 (16): 8288-8295. Kim B S, Kang J, Jun S, Kim H, Pak K, Kim G H, Heo H J, Kim Y |
Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 9 160 84-91. Shen Mingjing, Jiang Kanqiu, Sui Yiqun, Xu Zhonghua, Cui Hongxia, Wang Youyou, Zhang Huan, Xu Zhonghen, Xu Weihua, Ding Qifeng, Chen Yongbi |
TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs. Frontiers in molecular biosciences 2021 7 8 690500. Wang Kai, Feng Xingjun, Zheng Lingzhi, Chai Zeying, Yu Junhui, You Xinxin, Li Xiaodan, Cheng Xiaodo |
Extracellular Matrix-Associated Pathways Promote the Progression of Gastric Cancer by Impacting the Dendritic Cell Axis. International journal of general medicine 2021 10 14 6725-6739. Wang Zhenlin, Wang Zunyun, Hu Xianyu, Han Qijun, Chen Ke, Pang Ga |
Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism. Frontiers in cell and developmental biology 2021 10 9 700661. Hu Jialing, Xu Jiasheng, Feng Xiaojin, Li Yiran, Hua Fuzhou, Xu Guoh |
Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders. Human cell 2021 10 35 (1): 199-213. Yang Can, Zhang Zijing, Tang Xuemei, Zhang Xinju, Chen Yuming, Hu Tingting, Zhang Huating, Guan Ming, Zhang Xiuming, Wu Zhiyu |
Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer. Disease markers 2022 2022 3592990. Lin Haishan, Cao Bangw |
A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma. Frontiers in oncology 2022 12 897323. Dong Yi, Li Yingge, Yao Yi, Song Qib |
An immune-related gene prognostic risk index for pancreatic adenocarcinoma. Frontiers in immunology 2022 8 13 945878. Su Yang, Qi Ruoshan, Li Lanying, Wang Xu, Li Sijin, Zhao Xuan, Hou Rui, Ma Wen, Liu Dan, Zheng Junnian, Shi Mi |
The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis. Oxidative medicine and cellular longevity 2022 10 2022 3355365. Lu Feng, Wu Juan, Zou Hongpeng, Yang Xin, Wu Yongbing, Xu Jianj |
Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma. Frontiers in pharmacology 2023 6 14 1185418. Dongjie Sun, Haiying Zhang, Chi Zha |
Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: